• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
November 2023 Labs in Court

November 2023 Labs in Court

by Glenn S. Demby | Oct 20, 2023 | Essential, Lab Compliance Advisor, Laboratory Industry Report, Labs in Court, National Lab Reporter

This month’s roundup of cases includes Walgreens’ settlement with Theranos customers, kickbacks, and age discrimination.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Compliance Perspectives: When Do Cybersecurity Donations Violate Kickback Laws?

Compliance Perspectives: When Do Cybersecurity Donations Violate Kickback Laws?

by Glenn S. Demby | Oct 20, 2023 | Compliance Perspectives-lca, Essential, Lab Compliance Advisor, Laboratory Industry Report, National Lab Reporter

The compliance risks of giving referral sources software or equipment to ensure the security of protected health information.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Compliance Tool: Model Policy on Donating Cybersecurity Technology to Physicians

Compliance Tool: Model Policy on Donating Cybersecurity Technology to Physicians

by Glenn S. Demby | Oct 20, 2023 | Essential, Lab Compliance Advisor, Laboratory Industry Report, National Lab Reporter, Tool

This template aims to help lab leaders develop a policy for donations of cybersecurity technology that complies with safe harbor requirements.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
October 2023 Labs in Court

October 2023 Labs in Court

by Glenn S. Demby | Sep 25, 2023 | Essential, Lab Compliance Advisor, Laboratory Industry Report, Labs in Court, National Lab Reporter

Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Compliance Perspectives: How to Comply with the CMS 60-Day Overpayment Repayment Rule

Compliance Perspectives: How to Comply with the CMS 60-Day Overpayment Repayment Rule

by Glenn S. Demby | Sep 1, 2023 | Compliance Perspectives-lca, Essential, Lab Compliance Advisor

While overpayments may not be your fault, they expose your lab to the risk of liability under the Affordable Care Act.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com